Improvement in Quality of Life with OnabotulinumtoxinA for Cervical Dystonia: POSTURe

20205 citationsJournal Articlehybrid Open Access

Authors

Marc Petitclerc · Cégep de Lévis

Martin Cloutier · Clinique Neuro-Outaouais

Pierre Naud · Centre de Santé et de Services Sociaux de la Vieille-Capitale

Mélanie Langlois · Hôpital de l'Enfant-Jésus

Meetu Bhogal · Allergan (Canada)

Goran Davidović · Allergan (Canada)

Abstract

These real-world data indicate that after repeated, long-term use, onabotulinumtoxinA continues to be a safe and effective treatment for CD, improving HRQoL and work productivity.

Topics & Keywords

Botulinum Toxin and Related Neurological Disorders Neurological disorders and treatments Parkinson's Disease Mechanisms and Treatments

UN Sustainable Development Goals

Decent work and economic growth

Publication Details

Published in: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Volume 48, Issue 5, pp. 676-684

DOI: 10.1017/cjn.2020.275

Field-Weighted Citation Impact: 0.36